Colossal Biosciences announced on March 4, 2025, that it had created what it calls the “Colossal Woolly Mouse,” a living mouse engineered with multiple mammoth-like hair traits through simultaneous gene edits. The company says the result keeps it on schedule to produce a mammoth-like elephant calf by 2028. But outside geneticists have questioned whether engineering shaggy fur on a mouse meaningfully advances the far harder challenge of editing an elephant genome and bringing a cold-adapted calf to term.
Why the woolly mouse matters for Colossal’s 2028 deadline
The central tension behind the headline is scale. Colossal’s team edited multiple genes in mouse embryos at the same time, a technique called multiplex genome editing, and produced animals with visibly thicker, longer coats that resemble woolly mammoth hair. A preprint posted on bioRxiv details how the researchers targeted several mouse genes to recapitulate mammoth hair phenotypes. The experiment shows the company can stack cold-climate traits in a single editing pass rather than introducing them one at a time across many generations.
The problem is that mice and elephants are separated by roughly 90 million years of evolution, enormous differences in genome size, and radically different reproductive biology. Asian elephants have a gestation period of nearly 22 months, and no one has yet demonstrated successful multiplex CRISPR editing in elephant cell lines at the efficiency rates Colossal achieved in mice. If the editing efficiency the company observed in its mouse work does not translate to elephant cells within the next 18 months, the 2028 target will almost certainly slip by years. Elephant embryology is far less forgiving than mouse embryology: fewer embryos, longer development, and no established protocol for implanting a gene-edited embryo into a surrogate elephant mother.
What the preprint and press release actually show
Colossal’s press release described the woolly mouse as a proof of concept for trait engineering on the path to a mammoth. The company framed the result as evidence that its editing platform can rewrite multiple phenotypic traits simultaneously, a necessary step if the eventual goal is to install dozens of mammoth-specific adaptations into an Asian elephant genome. The bioRxiv preprint, which has not yet undergone formal peer review, provides the experimental methods, gene targets, and phenotyping data behind the claim.
The mice did grow visibly different coats. That is a real, observable outcome, and it confirms that Colossal’s editing tools can produce phenotypic changes in living animals. The company has also invested in the upstream science needed to identify which mammoth gene variants to target. Last year, Colossal announced $7.5 million in new investments for ancient DNA academic research projects, expanding partnerships that the firm says will supply additional mammoth sequence data for trait engineering.
Yet the distance between a fuzzy mouse and a cold-adapted elephant remains vast. External scientists cited in Nature’s reporting on the preprint expressed skepticism that hair changes in mice represent a significant step toward the larger de-extinction goal. Hair is one trait among many that a mammoth-like animal would need: subcutaneous fat layers, cold-tolerant hemoglobin, reshaped ear and tail anatomy to reduce heat loss, and behavioral adaptations are all part of the package. The woolly mouse addresses one visible trait and says nothing about the dozens of other edits required.
Gaps between the woolly mouse and a living mammoth proxy
No public data from Colossal shows successful multiplex editing of Asian elephant cells using the same approach applied to mice. The company has not released project milestone documents or independent timeline audits that would let outsiders verify whether the 2028 target rests on demonstrated technical progress or aspirational scheduling. The Associated Press confirmed the company’s public statements about the woolly mouse but found no independent verification of the broader timeline.
The reproductive bottleneck is the single largest obstacle. Even if Colossal achieves high-efficiency editing in elephant cell lines, the company would still need a viable method for creating an embryo from those edited cells and gestating it. Artificial wombs for large mammals do not exist at the scale required. Surrogate elephant pregnancies raise both technical and ethical questions that no research group has resolved. Each failed attempt would cost nearly two years of gestation time, making the margin for error razor-thin if the company hopes to present a living calf by 2028.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
